Detalhe da pesquisa
1.
Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.
BMC Med
; 15(1): 70, 2017 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28366170
2.
Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule.
BMC Infect Dis
; 17(1): 400, 2017 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28587665
3.
Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
J Antimicrob Chemother
; 66(3): 650-6, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21123286
4.
Treatment duration of febrile urinary tract infections.
Curr Infect Dis Rep
; 13(6): 571-8, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21882085
5.
Urinary proteins, vitamin D and genetic polymorphisms as risk factors for febrile urinary tract infection and relation with bacteremia: a case control study.
PLoS One
; 10(3): e0121302, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25807366
6.
Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections.
Thromb Res
; 133(5): 799-803, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24657035
7.
Diabetes and the course of febrile urinary tract infection.
Diabetes Care
; 36(12): e193-4, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24265368